Director/PDMR Shareholding

RNS Number : 3924B

Dechra Pharmaceuticals PLC

03 March 2014

 



3 March 2014

Dechra^® Pharmaceuticals PLC

(Dechra or the Company)

Director / PDMR shareholding

Exercise of LTIP options:

Dechra Pharmaceuticals PLC announces that on 28 February 2014, the following Director and PDMR exercised options over ordinary shares of 1p each in the Company. The options were granted to them on 22 December 2010 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP): 

Name	Capacity	Options Exercised	Shares Sold	Sale Price per share	Total beneficial shareholding following this announcement	Percentage of issued share capital
Ian Page	Director	78,656	37,080	£6.9129	906,643	1.035
Zoe Goulding	PDMR	8,989	4,238	£6.9129	11,933	0.014

The exercise of the LTIP options were subject to the achievement of performance conditions which vested at 100% of the total award.

Both Ian Page and Zoe Goulding have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

For further information, please contact:

Melanie Hall, Assistant Company Secretary             

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Its expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

RDSQKNDNPBKDBNK